Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Larimar Therapeutics (LRMR) Return on Assets (2016 - 2020)

Historic Return on Assets for Larimar Therapeutics (LRMR) over the last 7 years, with Q3 2020 value amounting to 0.09%.

  • Larimar Therapeutics' Return on Assets rose 4400.0% to 0.09% in Q3 2020 from the same period last year, while for Sep 2020 it was 0.09%, marking a year-over-year increase of 4400.0%. This contributed to the annual value of 0.72% for FY2019, which is 1800.0% down from last year.
  • Per Larimar Therapeutics' latest filing, its Return on Assets stood at 0.09% for Q3 2020, which was up 4400.0% from 0.24% recorded in Q2 2020.
  • In the past 5 years, Larimar Therapeutics' Return on Assets ranged from a high of 0.09% in Q3 2020 and a low of 0.93% during Q4 2019
  • In the last 5 years, Larimar Therapeutics' Return on Assets had a median value of 0.48% in 2018 and averaged 0.51%.
  • As far as peak fluctuations go, Larimar Therapeutics' Return on Assets tumbled by -4400bps in 2019, and later soared by 4400bps in 2020.
  • Quarter analysis of 5 years shows Larimar Therapeutics' Return on Assets stood at 0.42% in 2016, then decreased by -23bps to 0.52% in 2017, then rose by 7bps to 0.48% in 2018, then plummeted by -92bps to 0.93% in 2019, then surged by 90bps to 0.09% in 2020.
  • Its Return on Assets stands at 0.09% for Q3 2020, versus 0.24% for Q2 2020 and 0.91% for Q1 2020.